217 related articles for article (PubMed ID: 24700300)
1. Morbidity and mortality associated with gastrectomy for gastric cancer.
Papenfuss WA; Kukar M; Oxenberg J; Attwood K; Nurkin S; Malhotra U; Wilkinson NW
Ann Surg Oncol; 2014 Sep; 21(9):3008-14. PubMed ID: 24700300
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis.
Shridhar R; Dombi GW; Weber J; Hoffe SE; Meredith K; Konski A
Am J Clin Oncol; 2012 Jun; 35(3):216-21. PubMed ID: 21378540
[TBL] [Abstract][Full Text] [Related]
3. Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database.
Bartlett EK; Roses RE; Kelz RR; Drebin JA; Fraker DL; Karakousis GC
Surgery; 2014 Aug; 156(2):298-304. PubMed ID: 24947651
[TBL] [Abstract][Full Text] [Related]
4. Should gastric cardia cancers be treated with esophagectomy or total gastrectomy? A comprehensive analysis of 4,996 NSQIP/SEER patients.
Martin JT; Mahan A; Zwischenberger JB; McGrath PC; Tzeng CW
J Am Coll Surg; 2015 Apr; 220(4):510-20. PubMed ID: 25667138
[TBL] [Abstract][Full Text] [Related]
5. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.
Yamamoto M; Baba H; Kakeji Y; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Maehara Y
Hepatogastroenterology; 2004; 51(55):298-302. PubMed ID: 15011889
[TBL] [Abstract][Full Text] [Related]
6. [Impact of splenectomy and/or distal pancreatectomy in the prognosis of the proximal gastric cancer].
Mori Gonzales E; Celis J; Ruiz E; Payet E; Berrospi F; Chavez I; Young F; Luque C; Montes J
Rev Gastroenterol Peru; 2012; 32(1):32-43. PubMed ID: 22476176
[TBL] [Abstract][Full Text] [Related]
7. Postoperative morbidity and mortality after gastrectomy for gastric carcinoma.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 2001; 48(41):1517-20. PubMed ID: 11677999
[TBL] [Abstract][Full Text] [Related]
8. D2 lymphadenectomy with surgical ex vivo dissection into node stations for gastric adenocarcinoma can be performed safely in Western patients and ensures optimal staging.
Schmidt B; Chang KK; Maduekwe UN; Look-Hong N; Rattner DW; Lauwers GY; Mullen JT; Yang HK; Yoon SS
Ann Surg Oncol; 2013 Sep; 20(9):2991-9. PubMed ID: 23760588
[TBL] [Abstract][Full Text] [Related]
9. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
[TBL] [Abstract][Full Text] [Related]
10. Morbidity, mortality and survival after stomach resection with or without splenectomy--the single centre observations.
Stojcev Z; Bobowicz M; Jarząb M; Pawłowska-Stojcev T; Banasiewicz T
Pol Przegl Chir; 2013 Aug; 85(8):433-7. PubMed ID: 24009053
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer.
Sun Z; Nussbaum DP; Speicher PJ; Czito BG; Tyler DS; Blazer DG
J Surg Oncol; 2015 Jul; 112(1):46-50. PubMed ID: 26179329
[TBL] [Abstract][Full Text] [Related]
12. D2 or not D2? The gastrectomy question.
Lewis WG; Edwards P; Barry JD; Khan S; Dhariwal D; Hodzovic I; Allison MC; Shute K
Gastric Cancer; 2002; 5(1):29-34. PubMed ID: 12021857
[TBL] [Abstract][Full Text] [Related]
13. Mortality and Morbidity and Disease Free Survival after D1 and D2 Gastrectomy for Stomach Adenocarcinomas.
Talaiezadeh AH; Asgari M; Zargar MA
Asian Pac J Cancer Prev; 2015; 16(13):5253-6. PubMed ID: 26225661
[TBL] [Abstract][Full Text] [Related]
14. Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients.
Biffi R; Chiappa A; Luca F; Pozzi S; Lo Faso F; Cenciarelli S; Andreoni B
J Surg Oncol; 2006 Apr; 93(5):394-400. PubMed ID: 16550575
[TBL] [Abstract][Full Text] [Related]
15. Lymph node dissection in resectable advanced gastric cancer.
de Steur WO; Dikken JL; Hartgrink HH
Dig Surg; 2013; 30(2):96-103. PubMed ID: 23867585
[TBL] [Abstract][Full Text] [Related]
16. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network.
Verlato G; Roviello F; Marchet A; Giacopuzzi S; Marrelli D; Nitti D; de Manzoni G
Ann Surg Oncol; 2009 Mar; 16(3):594-602. PubMed ID: 19118437
[TBL] [Abstract][Full Text] [Related]
17. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
18. Gastrectomy circumstances that influence early postoperative outcome.
Schwarz RE; Zagala-Nevarez K
Hepatogastroenterology; 2002; 49(48):1742-6. PubMed ID: 12397783
[TBL] [Abstract][Full Text] [Related]
19. [Morbidity and mortality in gastric cancer surgery--analysis of 468 cases with gastric adenocarcinoma].
Necula A; Vlad L; Iancu C; Munteanu D; Puia C; Bălă O; AlHajaar N; Pop F; Radu H; Osian G; Graur F; Furcea L; Stanca M; Molnar G; Mocanu L
Chirurgia (Bucur); 2008; 103(5):529-37. PubMed ID: 19260628
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.
Reis E; Kama NA; Doganay M; Atli M; Dolapci M
Hepatogastroenterology; 2002; 49(46):1167-71. PubMed ID: 12143228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
